| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $16.08M | $17.97M | $5.23M | $1.98M | $3.60M |
| Operating Income | -$16.08M | -$17.97M | -$2.27M | -$1.98M | -$3.60M |
| Interest Expense | $422.00 | – | $7.11K | $100.00K | $100.00K |
| Tax Expense | – | – | – | – | – |
| Net Income | -$15.72M | -$23.75M | $139.00K | $15.07M | $4.71M |
| EPS (basic) | -2.1300 | -0.5500 | -0.0900 | – | – |
| EPS (diluted) | -2.1300 | -0.5500 | -0.0900 | – | – |
| Shares (diluted) | $7.39M | $42.82M | $40.40M | – | – |